Delivering 60 million doses Covid 19 vaccine drug substance.
Add to calOnline
Mike Quin - Head of Cell Culture Manufacturing, FUJIFILM Diosynth Biotechnologies, Billingham.
Synopsis:
In September 2020 Fujifilm Diosynth Biotechnologies, a leading global biologic drug manufacturer based in Teesside, were contracted to produce the Novavax Covid-19 vaccine on behalf of the UK Government. This presentation will describe the process for manufacturing a biologic drug or vaccine and show how challenges were overcome, during global pandemic conditions, to enable manufacture of the vaccine drug substance to commence earlier than the agreed start date, with only 160 days' preparation.
CIE Lectures is inviting you to a scheduled Webex meeting.
Wednesday, 12 May 2021
18:00 | (UTC+01:00) Dublin, Edinburgh, Lisbon, London | 1 hr 30 mins
Join meeting
More ways to join:
Join from the meeting link
https://clevelandinstitutionofengineers.my.webex.com/webappng/sites/clevelandinstitutionofengineers.my/meeting/download/bff3e26bc69449988df90889aaccc142?siteurl=clevelandinstitutionofengineers.my&MTID=m54d42ab0baa80247eba6778709be20a4